πŸ‡ΊπŸ‡Έ FDA
Patent

US 9662396

Stable aqueous formulations of etanercept

granted A61KA61K2039/505A61K38/1793

Quick answer

US patent 9662396 (Stable aqueous formulations of etanercept) held by Coherus BioSciences, Inc. expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Coherus BioSciences, Inc.
Grant date
Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K38/1793, A61K47/02, A61K47/10